It would be interesting to evaluate the association of [177Lu]Lu-PSMA-617 and radio-sensitizers such as chemotherapy, the alpha PSMA therapy or the increase in [177Lu]Lu-PSMA-617 activity to improve the efficacy of RLT in salivary gland carcinomas with moderate uptake of PSMA. The gene discussed is FOLH1; the disease is salivary gland carcinoma.